OrthoPediatrics Corp. (KIDS)

US — Healthcare Sector
Peers: OFIX  SGHT  NPCE  CVRX  IRTC  HSKA  ELMD  NUVA  CNMD  LUNG  SIBN  OSA  LIVN  SRDX  GKOS  FNA 

Automate Your Wheel Strategy on KIDS

With Tiblio's Option Bot, you can configure your own wheel strategy including KIDS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol KIDS
  • Rev/Share 9.1453
  • Book/Share 16.5578
  • PB 1.3625
  • Debt/Equity 0.0696
  • CurrentRatio 6.1874
  • ROIC -0.0687

 

  • MktCap 504296840.0
  • FreeCF/Share -1.5878
  • PFCF -13.6714
  • PE -11.628
  • Debt/Assets 0.0514
  • DivYield 0
  • ROE -0.1127

 

  • Rating B-
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 5
  • P/B Score 3
  • D/E Score 3

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Initiation KIDS Lake Street -- Buy -- $37 April 7, 2025

News

OrthoPediatrics (KIDS) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
KIDS
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Positive

The headline numbers for OrthoPediatrics (KIDS) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Read More
image for news OrthoPediatrics (KIDS) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
OrthoPediatrics (KIDS) Reports Q1 Loss, Tops Revenue Estimates
KIDS
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Negative

OrthoPediatrics (KIDS) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to loss of $0.30 per share a year ago.

Read More
image for news OrthoPediatrics (KIDS) Reports Q1 Loss, Tops Revenue Estimates
OrthoPediatrics Corp. (KIDS) Q4 2024 Earnings Call Transcript
KIDS
Published: March 04, 2025 by: Seeking Alpha
Sentiment: Neutral

OrthoPediatrics Corp. (NASDAQ:KIDS ) Q4 2024 Earnings Conference Call March 4, 2025 4:30 PM ET Company Participants Trip Taylor - Gilmartin Group, IR David Bailey - President and CEO Fred Hite - Chief Operating and Financial Officer Conference Call Participants Ryan Zimmerman - BTIG Rick Wise - Stifel Matthew O'Brien - Piper Sandler Joseph Conway - Needham & Company Operator Hello. And welcome to OrthoPediatrics Corporation's Fourth Quarter and Full Year 2024 Earnings Conference Call.

Read More
image for news OrthoPediatrics Corp. (KIDS) Q4 2024 Earnings Call Transcript
Compared to Estimates, OrthoPediatrics (KIDS) Q4 Earnings: A Look at Key Metrics
KIDS
Published: March 04, 2025 by: Zacks Investment Research
Sentiment: Neutral

While the top- and bottom-line numbers for OrthoPediatrics (KIDS) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Read More
image for news Compared to Estimates, OrthoPediatrics (KIDS) Q4 Earnings: A Look at Key Metrics
OrthoPediatrics (KIDS) Reports Q4 Loss, Misses Revenue Estimates
KIDS
Published: March 04, 2025 by: Zacks Investment Research
Sentiment: Negative

OrthoPediatrics (KIDS) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to loss of $0.23 per share a year ago.

Read More
image for news OrthoPediatrics (KIDS) Reports Q4 Loss, Misses Revenue Estimates

About OrthoPediatrics Corp. (KIDS)

  • IPO Date 2017-10-13
  • Website https://www.orthopediatrics.com
  • Industry Medical - Devices
  • CEO Mr. David R. Bailey
  • Employees 562

OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.